Geoffrey Thomas Tucker
Président chez International Pharmaceutical Federation
Profil
Geoffrey Thomas Tucker is the founder of Certara UK Ltd., which was founded in 2001.
He held the title of Chairman at Certara UK Ltd.
Dr. Tucker's current job positions include Chairman-Elect at the International Pharmaceutical Federation, Professor at The University of Sheffield, President at the International Society for the Study of Xenobiotics (since 2015), and Member at both the British Pharmacological Society and The British Toxicology Society.
Dr. Tucker's former job positions include Director at Diurnal Group Ltd.
and Principal at the International Society for the Study of Xenobiotics.
Dr. Tucker's education history includes an undergraduate degree from the University of London in 1964, a doctorate degree from the University of London in 1967, and a doctorate degree from the University of Uppsala.
Postes actifs de Geoffrey Thomas Tucker
Sociétés | Poste | Début |
---|---|---|
The University of Sheffield | Corporate Officer/Principal | 08/01/2010 |
International Pharmaceutical Federation
International Pharmaceutical Federation Miscellaneous Commercial ServicesCommercial Services The International Pharmaceutical Federation (FIP) is an organization that focuses on higher education for health professionals, specifically in the field of pharmaceutical education. The non-profit company is based in The Hague, Netherlands. The Dutch company's FIP UNESCO-UNITWIN program was the first of its kind. | Président | - |
British Pharmacological Society
British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | Corporate Officer/Principal | - |
The British Toxicology Society | Corporate Officer/Principal | - |
International Society for the Study of Xenobiotics | President | 21/01/2014 |
Anciens postes connus de Geoffrey Thomas Tucker
Sociétés | Poste | Fin |
---|---|---|
International Society for the Study of Xenobiotics | Corporate Officer/Principal | - |
DIUL GROUP | Directeur/Membre du Conseil | - |
Certara UK Ltd.
Certara UK Ltd. BiotechnologyHealth Technology Certara UK Ltd. provides platforms for the modeling and simulation of pharmacokinetics and pharmacodynamics in virtual human populations and virtual laboratory animals. The company was founded by Geoffrey Thomas Tucker, Amin Rostami-Hodjegan, and John Evans on May 15, 2001 and is headquartered in London, the United Kingdom. | Fondateur | - |
Formation de Geoffrey Thomas Tucker
University of London | Doctorate Degree |
University of Uppsala | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 6 |
---|---|
Certara UK Ltd.
Certara UK Ltd. BiotechnologyHealth Technology Certara UK Ltd. provides platforms for the modeling and simulation of pharmacokinetics and pharmacodynamics in virtual human populations and virtual laboratory animals. The company was founded by Geoffrey Thomas Tucker, Amin Rostami-Hodjegan, and John Evans on May 15, 2001 and is headquartered in London, the United Kingdom. | Health Technology |
International Society for the Study of Xenobiotics | |
International Pharmaceutical Federation
International Pharmaceutical Federation Miscellaneous Commercial ServicesCommercial Services The International Pharmaceutical Federation (FIP) is an organization that focuses on higher education for health professionals, specifically in the field of pharmaceutical education. The non-profit company is based in The Hague, Netherlands. The Dutch company's FIP UNESCO-UNITWIN program was the first of its kind. | Commercial Services |
Diurnal Group Ltd.
Diurnal Group Ltd. Pharmaceuticals: MajorHealth Technology Diurnal Group plc engages in the development of products for the life-long treatment of chronic endocrine conditions, including congenital adrenal hyperplasia and adrenal insufficiency. It focuses on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena. The company was founded by Richard John Martin Ross in 2004 and is headquartered in Cardiff, the United Kingdom. | Health Technology |
British Pharmacological Society
British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | Miscellaneous |
The British Toxicology Society |